Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW)

CUSIP: G0705H111

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / *W EXP 10/01/202
Total 13F shares
6,316,695
Share change
+85,766
Total reported value
$512,546
Price per share
$0.08
Number of holders
33
Value change
+$7,965
Number of buys
4
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP G0705H111?
CUSIP G0705H111 identifies BDMDW - Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW) as of Q2 2025

As of 30 Jun 2025, Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,316,695 shares. The largest 10 holders included CLEAR STREET LLC, Sculptor Capital LP, ARISTEIA CAPITAL, L.L.C., Calamos Advisors LLC, Linden Advisors LP, Kepos Capital LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Davidson Kempner Capital Management LP, GOLDMAN SACHS GROUP INC, and WOLVERINE ASSET MANAGEMENT LLC. This page lists 33 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.